Yanle Ye1, Zhishan Zhang1, Hong Zhao2

  • 1Central Laboratory, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China.

PubMed
概括

免疫检查点阻断 (ICB) 新辅助疗法改善了乳腺癌的结果,但增加了严重的副作用. 仔细监测至关重要,以管理与治疗相关的不良事件,并防止停止治疗.